125 related articles for article (PubMed ID: 38583954)
1. Angiotensin II Is Involved in MLKL Activation During the Development of Heart Failure Following Myocardial Infarction in Rats.
Marunouchi T; Onda S; Kurasawa M; Tanonaka K
Biol Pharm Bull; 2024; 47(4):809-817. PubMed ID: 38583954
[TBL] [Abstract][Full Text] [Related]
2. Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.
Marunouchi T; Nishiumi C; Iinuma S; Yano E; Tanonaka K
Eur J Pharmacol; 2021 May; 898():173987. PubMed ID: 33640405
[TBL] [Abstract][Full Text] [Related]
3. Effects of 17-AAG on the RIP1/RIP3/MLKL pathway during the development of heart failure following myocardial infarction in rats.
Marunouchi T; Ito T; Onda S; Kyo L; Takahashi K; Uchida M; Yano E; Tanonaka K
J Pharmacol Sci; 2021 Oct; 147(2):192-199. PubMed ID: 34384567
[TBL] [Abstract][Full Text] [Related]
4. Different signalling in infarcted and non-infarcted areas of rat failing hearts: A role of necroptosis and inflammation.
Lichý M; Szobi A; Hrdlička J; Horváth C; Kormanová V; Rajtík T; Neckář J; Kolář F; Adameová A
J Cell Mol Med; 2019 Sep; 23(9):6429-6441. PubMed ID: 31328381
[TBL] [Abstract][Full Text] [Related]
5. Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.
Yoshida H; Takahashi M; Tanonaka K; Maki T; Nasa Y; Takeo S
Br J Pharmacol; 2001 Sep; 134(1):150-60. PubMed ID: 11522607
[TBL] [Abstract][Full Text] [Related]
6. Arctiin protects rat heart against ischemia/reperfusion injury via a mechanism involving reduction of necroptosis.
Chen H; Tang LJ; Tu H; Zhou YJ; Li NS; Luo XJ; Peng J
Eur J Pharmacol; 2020 May; 875():173053. PubMed ID: 32135123
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor--a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats.
Ahmed MS; Øie E; Vinge LE; Yndestad A; Øystein Andersen G; Andersson Y; Attramadal T; Attramadal H
J Mol Cell Cardiol; 2004 Mar; 36(3):393-404. PubMed ID: 15010278
[TBL] [Abstract][Full Text] [Related]
8. GSK2795039 prevents RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis in doxorubicin-induced heart failure through inhibition of NADPH oxidase-derived oxidative stress.
Zhang XJ; Li L; Wang AL; Guo HX; Zhao HP; Chi RF; Xu HY; Yang LG; Li B; Qin FZ; Wang JP
Toxicol Appl Pharmacol; 2023 Mar; 463():116412. PubMed ID: 36764612
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure.
Isidoro Tavares N; Philip-Couderc P; Baertschi AJ; Lerch R; Montessuit C
Cardiovasc Res; 2009 Sep; 83(4):726-36. PubMed ID: 19460779
[TBL] [Abstract][Full Text] [Related]
10. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril.
Toga W; Tanonaka K; Takeo S
Biol Pharm Bull; 2007 Jan; 30(1):105-10. PubMed ID: 17202668
[TBL] [Abstract][Full Text] [Related]
11. Klotho attenuates angiotensin II‑induced cardiotoxicity through suppression of necroptosis and oxidative stress.
Yu S; Yang H; Guo X; Sun Y
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33215215
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
Tsutsumi Y; Matsubara H; Ohkubo N; Mori Y; Nozawa Y; Murasawa S; Kijima K; Maruyama K; Masaki H; Moriguchi Y; Shibasaki Y; Kamihata H; Inada M; Iwasaka T
Circ Res; 1998 Nov; 83(10):1035-46. PubMed ID: 9815151
[TBL] [Abstract][Full Text] [Related]
13. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
14. MLKL-mediated necroptosis is a target for cardiac protection in mouse models of type-1 diabetes.
Cao T; Ni R; Ding W; Ji X; Li L; Liao G; Lu Y; Fan GC; Zhang Z; Peng T
Cardiovasc Diabetol; 2022 Aug; 21(1):165. PubMed ID: 36030201
[TBL] [Abstract][Full Text] [Related]
15. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
16. RIP1/RIP3/MLKL-mediated necroptosis contributes to vinblastine-induced myocardial damage.
Zhou H; Liu L; Ma X; Wang J; Yang J; Zhou X; Yang Y; Liu H
Mol Cell Biochem; 2021 Feb; 476(2):1233-1243. PubMed ID: 33247805
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor binding following myocardial infarction in the rat.
Sun Y; Weber KT
Cardiovasc Res; 1994 Nov; 28(11):1623-8. PubMed ID: 7842454
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with trandolapril on Hsp72 and Hsp73 induction of the failing heart following myocardial infarction.
Tanonaka K; Toga W; Yoshida H; Furuhama K; Takeo S
Br J Pharmacol; 2001 Nov; 134(5):969-76. PubMed ID: 11682444
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
20. Analysis of necroptotic proteins in failing human hearts.
Szobi A; Gonçalvesová E; Varga ZV; Leszek P; Kuśmierczyk M; Hulman M; Kyselovič J; Ferdinandy P; Adameová A
J Transl Med; 2017 Apr; 15(1):86. PubMed ID: 28454582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
